Postoperative Pulmonary Function and Structural Remodelling After Lobectomy in Patients With and Without Chronic Obstructive Pulmonary Disease

慢性阻塞性肺疾病患者和非慢性阻塞性肺疾病患者肺叶切除术后的肺功能和结构重塑

阅读:4

Abstract

OBJECTIVES: Quantitative assessment of lung structure provides insights beyond conventional postoperative function prediction. This study examined how preoperative chronic obstructive pulmonary disease (COPD) status and emphysema distribution influence postoperative pulmonary function and structural remodelling using 3-dimensional computed tomography (3D-CT) cluster analysis. METHODS: We retrospectively analysed 426 lobectomy cases performed between 2018 and 2023. Patients were stratified into the COPD and non-COPD groups. Predicted postoperative FEV1.0 was estimated using 3D-CT volumetry, and the measured-to-predicted FEV1.0 ratio (MPFR) was calculated. Structural parameters, including D-value (reflecting alveolar complexity) and low-attenuation area (LAA), were measured pre- and postoperatively using 3D-CT. MPFR, % change in D-value (%D-value), and LAA (%LAA) were compared between the groups using Mann-Whitney U tests. Subgroup analysis was performed based on whether the resected lobe had a higher or lower D-value than the whole lung. RESULTS: Patients with COPD exhibited a significantly higher MPFR than those without COPD (117.9% vs 110.7%, P < .001). %D-value did not differ significantly between the groups (99.7% vs 98.1%, P = .476), whereas %LAA was significantly higher in non-COPD patients (134.9% vs 117.6%, P = .005). In subgroup analyses according to the presence of emphysematous resected lobes, MPFR and %D-value did not differ between the groups, and no significant difference in %LAA was observed. CONCLUSIONS: Patients with COPD maintain better-than-predicted postoperative function without additional structural loss, whereas non-COPD patients show volume-driven increases in LAA. Integrating functional and structural 3D-CT indexes-MPFR, D-value, and LAA-enables a comprehensive evaluation of postoperative lung remodelling, potentially improving risk stratification and surgical planning. CLINICAL REGISTRATION NUMBER: G-441; approved on May 12, 2025.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。